Warning letterPosted September 30, 2025

FDA warning letter to Time Challenger Labs International, Inc.

CGMP/Dietary Supplement/Adulterated/Misbranded

FDA's record ↗

FDA posted a warning letter to Time Challenger Labs International, Inc. on September 30, 2025; the letter is dated September 18, 2025. Subject: CGMP/Dietary Supplement/Adulterated/Misbranded. Issuing office: Human Foods Program.

On the record

Company
Time Challenger Labs International, Inc.
Subject
CGMP/Dietary Supplement/Adulterated/Misbranded
Issuing office
Human Foods Program
Letter dated
2025-09-18
Posted by FDA
2025-09-30
Source
FDA warning letters ↗

CFR cited

The record cites 8 sections of 21 CFR Parts 101 and 111.

The full record

An account shows the violations FDA described and each CFR section it cited.

What a warning letter is

A warning letter is FDA's notice to a company that it found significant violations of federal requirements. FDA asks for a written response, normally within 15 working days. The letter is advisory: it states the agency's position and is not a final agency action.

More

Watch Time Challenger Labs International, Inc

A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.

From FDA warning letters. The record may have changed since it was read.

Approve Suite is not affiliated with FDA, or with Time Challenger Labs International, Inc.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.